ABILITY Neurotech is developing an implantable brain–computer interface designed to restore autonomy for people living with paralysis. The company’s system focuses on direct neural interfacing with the motor cortex to enable communication between the brain and external devices. Its platform combines implantable hardware with supporting electronics to record and stimulate neural activity at high resolution. The overall goal is to translate neural intent into functional outputs that support movement and interaction.

The technology captures neural signals associated with motor intent, processes them through decoding algorithms, and transmits the resulting commands to external assistive systems. In addition to recording, the interface supports targeted stimulation, enabling bidirectional communication between the brain and the device. This closed-loop architecture is intended to improve signal reliability and long-term usability compared to purely recording-based systems. The implant is designed for chronic use, emphasizing stability, precision, and scalability.

ABILITY Neurotech positions its solution within the clinical neuroprosthetics space, targeting individuals with paralysis resulting from spinal cord injury or neurological disease. The system is intended for therapeutic and assistive use rather than consumer applications, with deployment aligned to regulated clinical pathways. Primary use cases include restoring voluntary control over digital interfaces, mobility aids, or other assistive technologies that improve independence and quality of life.